Enforcement record
Administrative Guidance disclosure naming 株式会社こころ
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
Administrative Guidance
Law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
Authority
Ministry of Health, Labour and Welfare
Action date
28 July 2020
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Queued for preservation
- Captured: Jul 12, 2026, 03:34 PM JST
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Available sources and saved files are listed in the public documents section below.
Public documents and saved materials
View the original publications, see what was preserved, or download each file below.
Loading materials…
Action summary
- Company
- 株式会社こころJapanese onlyOriginal: 株式会社こころ
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- Administrative Guidance行政指導
- Action date
- 28 July 2020
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 健康食品
Violation
Based on the submission of two types of CBD products, a total of eight products, the ingredients were analyzed. The analysis revealed that three units of CBD Oil Pro900 (10 mL capacity) and two units of CBD Oil Pro2700 (30 mL capacity) contained trace amounts of the cannabis component THC.
Show original Japanese text
同社が回収したCBD製品２種類８製品の提出を受け、成分の分析を行いました。分析の結果、CBDオイルPro900（容量10mL）3製品、CBDオイルPro2700（容量30mL）2製品から、微量の大麻成分THCが検出されました。
Compliance context
Low-mediumAdministrative guidance or supervision was publicly disclosed by the authority.
Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.
Use as a monitoring signal. Confirm details before treating it as a formal sanction.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.